Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease

Published:2022-03-17 Issue:3 Volume:23 Page:0106
ISSN:1530-6550
Container-title:Reviews in Cardiovascular Medicine
language:en
Short-container-title:Rev. Cardiovasc. Med.

Author:

Nevola Riccardo,Alfano Maria,Pafundi Pia Clara,Brin Chiara,Gragnano Felice,Calabrò Paolo,Adinolfi Luigi Elio,Rinaldi Luca,Sasso Ferdinando Carlo,Caturano Alfredo

Publisher

IMR Press

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care;Biomedicines;2024-09-07

2. Examining the Impact of Ertugliflozin on Cardiovascular Outcomes in Patients with Diabetes and Metabolic Syndrome: A Systematic Review of Clinical Trials;Pharmaceuticals;2024-07-11

3. Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes;Nature Reviews Nephrology;2024-06-18

4. Gliflozins - what's new in practise;Medicína pro praxi;2024-05-17

5. XBP1-mediated transcriptional regulation of SLC5A1 in human epithelial cells in disease conditions;Cell & Bioscience;2024-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP